Trials / Completed
CompletedNCT02568059
The Clinical Safety of Alcoholic Extract Sahastara Remedy of Extract Capsule in Healthy Volunteers
The Clinical Safety of Alcoholic Extract Sahastara Remedy of Extract Capsule in Healthy Volunteers (Clinical Trial Phase I)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Thammasat University · Academic / Other
- Sex
- All
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The clinical safety of Sahastara remedy alcoholic extract in healthy volunteers. Investigators will investigate safety of 100 and 200 mg of Sahastara remedy extract capsule in healthy volunteers. This is Clinical trial Phase I.
Detailed description
The sahastara remedy (SHT) is a Thai traditional medicine that is use to relieve pain of musculoskeletal problem. There is study shown that SHT extract was not found acute and chronic toxicity in rat. However, there is no study regarding safety in human. Thus, this study is a clinical trial Phase I that investigate clinical safety of SHT alcoholic extract in healthy volunteers. The clinical safety will monitor for 28 days in continuously use of 100 and 200 mg SHT extraction 3 time a day and after stop intervention for 14 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sahastara remedy alcoholic extract | comparison of different dose of drug |
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2015-10-05
- Last updated
- 2016-10-18
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT02568059. Inclusion in this directory is not an endorsement.